Cargando…

Pharmacoepigenetics in Heart Failure

Epigenetics studies inheritable changes of genes and gene expression that do not concern DNA nucleotide variation. Such modifications include DNA methylation, several forms of histone modification, and microRNAs. From recent studies, we know not only that genetic changes account for heritable phenot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mateo Leach, Irene, van der Harst, Pim, de Boer, Rudolf A.
Formato:	Texto
Lenguaje:	English
Publicado:	Current Science Inc. 2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875470/ https://www.ncbi.nlm.nih.gov/pubmed/20424992 http://dx.doi.org/10.1007/s11897-010-0011-y

Ejemplares similares

Promises and challenges in pharmacoepigenetics
por: Smith, Delaney A., et al.
Publicado: (2023)

Pharmacoepigenetics in type 2 diabetes: is it clinically relevant?
por: Ling, Charlotte
Publicado: (2022)

Aging, telomeres and heart failure
por: Wong, Liza S. M., et al.
Publicado: (2010)

Rapid Collection of Biospecimens by Automated Identification of Patients Eligible for Pharmacoepigenetic Studies
por: Sun, Yan V., et al.
Publicado: (2013)

Telomere Length of Circulating Leukocyte Subpopulations and Buccal Cells in Patients with Ischemic Heart Failure and Their Offspring
por: Wong, Liza S. M., et al.
Publicado: (2011)

Editorial: Molecular Targeted Therapy in Oncology: Lessons From Pharmacogenetics and Pharmacoepigenetics
por: Imani, Saber, et al.
Publicado: (2022)

Do changes in DNA methylation mediate or interact with SNP variation? A pharmacoepigenetic analysis
por: Fisher, Virginia A., et al.
Publicado: (2018)

The impact of coronary artery disease risk loci on ischemic heart failure severity and prognosis: association analysis in the COntrolled ROsuvastatin multiNAtional trial in heart failure (CORONA)
por: Haver, Vincent G, et al.
Publicado: (2014)

Sirtuins in Alzheimer’s Disease: SIRT2-Related GenoPhenotypes and Implications for PharmacoEpiGenetics
por: Cacabelos, Ramón, et al.
Publicado: (2019)

Renal dysfunction is associated with shorter telomere length in heart failure
por: Wong, Liza S. M., et al.
Publicado: (2009)

Inhibition of Interleukin-6 Receptor in a Murine Model of Myocardial Ischemia-Reperfusion
por: Hartman, Minke H. T., et al.
Publicado: (2016)

Statins in the Treatment of Chronic Heart Failure: A Systematic Review
por: van der Harst, Pim, et al.
Publicado: (2006)

Prenatal medication exposure and epigenetic outcomes: a systematic literature review and recommendations for prenatal pharmacoepigenetic studies
por: Olstad, Emilie Willoch, et al.
Publicado: (2021)

Identification of 15 novel risk loci for coronary artery disease and genetic risk of recurrent events, atrial fibrillation and heart failure
por: Verweij, Niek, et al.
Publicado: (2017)

Plasma calcidiol, calcitriol, and parathyroid hormone and risk of new onset heart failure in a population‐based cohort study
por: Meems, Laura M. G., et al.
Publicado: (2016)

A Genome-Wide Association Study of Circulating Galectin-3
por: de Boer, Rudolf A., et al.
Publicado: (2012)

Telomere biology in healthy aging and disease
por: Oeseburg, Hisko, et al.
Publicado: (2009)

Genetic study links components of the autonomous nervous system to heart-rate profile during exercise
por: Verweij, Niek, et al.
Publicado: (2018)

Heart Rate Recovery 10 Seconds After Cessation of Exercise Predicts Death
por: van de Vegte, Yordi J., et al.
Publicado: (2018)

Galectin-3 in Cardiac Remodeling and Heart Failure
por: de Boer, Rudolf A., et al.
Publicado: (2010)

Clonal haematopoiesis of indeterminate potential: associations with heart failure incidence, clinical parameters and biomarkers
por: Shi, Canxia, et al.
Publicado: (2022)

Pharmacoepigenetics of hypertension: genome-wide methylation analysis of responsiveness to four classes of antihypertensive drugs using a double-blind crossover study design
por: Nuotio, Marja-Liisa, et al.
Publicado: (2022)

Rodent heart failure models do not reflect the human circulating microRNA signature in heart failure
por: Vegter, Eline L., et al.
Publicado: (2017)

Genetics and the heart rate response to exercise
por: van de Vegte, Yordi J., et al.
Publicado: (2019)

Age dependent associations of risk factors with heart failure: pooled population based cohort study
por: Tromp, Jasper, et al.
Publicado: (2021)

Common risk factors for heart failure and cancer
por: Meijers, Wouter C, et al.
Publicado: (2019)

Erratum to: Galectin-3 in Cardiac Remodeling and Heart Failure
por: de Boer, Rudolf A., et al.
Publicado: (2012)

Leukocyte telomere length and left ventricular function after acute ST-elevation myocardial infarction: data from the glycometabolic intervention as adjunct to primary coronary intervention in ST elevation myocardial infarction (GIPS-III) trial
por: Haver, Vincent G., et al.
Publicado: (2015)

Heart failure medication dosage and survival in women and men seen at outpatient clinics
por: Bots, Sophie Heleen, et al.
Publicado: (2021)

Haloperidol induces pharmacoepigenetic response by modulating miRNA expression, global DNA methylation and expression profiles of methylation maintenance genes and genes involved in neurotransmission in neuronal cells
por: Swathy, Babu, et al.
Publicado: (2017)

Lifestyle components: Self-reported physical activity, nutritional status, sleep quality and incident atrial fibrillation
por: Siland, Joylene E., et al.
Publicado: (2020)

Biomarkers in heart failure with preserved ejection fraction
por: Meijers, W. C., et al.
Publicado: (2016)

Transforming heart failure and cardio‐oncology care during COVID‐19
por: Bracun, Valentina, et al.
Publicado: (2020)

Gene Set Enrichment Analyses: lessons learned from the heart failure phenotype
por: Tragante, Vinicius, et al.
Publicado: (2017)

The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure
por: Santema, Bernadet T., et al.
Publicado: (2019)

Emerging role of liver X receptors in cardiac pathophysiology and heart failure
por: Cannon, Megan V., et al.
Publicado: (2015)

The year in cardiovascular medicine 2022: the top 10 papers in heart failure and cardiomyopathies
por: de Boer, Rudolf A, et al.
Publicado: (2023)

Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure
por: Santema, Bernadet T., et al.
Publicado: (2020)

ACE-inhibitors, Beta-blockers or the Combination in Heart Failure: Is It Just an A–B–C ?: EDITORIAL to: Effects of beta-blockade and ACE inhibition on B-type natriuretic peptides in stable patients with systolic heart failure by Rosenberg et al.
por: de Boer, Rudolf A., et al.
Publicado: (2008)

Variability of biomarkers in patients with chronic heart failure and healthy controls
por: Meijers, Wouter C., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_e68u8u2hqm8f24u1h6716mj9c8